Back to Search Start Over

Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells.

Authors :
Kasioumi P
Vrazeli P
Vezyraki P
Zerikiotis S
Katsouras C
Damalas A
Angelidis C
Source :
International journal of oncology [Int J Oncol] 2019 Mar; Vol. 54 (3), pp. 821-832. Date of Electronic Publication: 2018 Dec 12.
Publication Year :
2019

Abstract

Heat shock protein 70 (Hsp70; also known as HSP70A1A) is one of the most induced proteins in cancer cells; however, its role in cancer has not yet been fully elucidated. In the present study, we proposed a hypothetical model in which the silencing of Hsp70 enhanced the metastatic properties of the HeLa, A549 and MCF7 cancer cell lines. We consider that the inability of cells to form cadherin‑catenin complexes in the absence of Hsp70 stimulates their detachment from neighboring cells, which is the first step of anoikis and metastasis. Under these conditions, an epithelial‑to‑mesenchymal transition (EMT) pathway is activated that causes cancer cells to acquire a mesenchymal phenotype, which is known to possess a higher ability for migration. Therefore, we herein provide evidence of the dual role of Hsp70 which, according to international literature, first establishes a cancerous environment and then, as suggested by our team, regulates the steps of the metastatic process, including EMT and migration. Finally, the trigger for the anti‑metastatic properties that are acquired by cancer cells in the absence of Hsp70 appears to be the destruction of the Hsp70‑dependent heterocomplexes of E‑cadherin/catenins, which function like an anchor between neighboring cells.

Details

Language :
English
ISSN :
1791-2423
Volume :
54
Issue :
3
Database :
MEDLINE
Journal :
International journal of oncology
Publication Type :
Academic Journal
Accession number :
30569142
Full Text :
https://doi.org/10.3892/ijo.2018.4666